KPNB1 modulates the Machado-Joseph disease protein ataxin-3 through activation of the mitochondrial protease CLPP. [PDF]
Abeditashi M +11 more
europepmc +1 more source
Neuropeptide Y (NPY) intranasal delivery alleviates Machado-Joseph disease. [PDF]
Duarte-Neves J +2 more
europepmc +1 more source
A Variant in Genes of the NPY System as Modifier Factor of Machado-Joseph Disease in the Chinese Population. [PDF]
Ding D +7 more
europepmc +1 more source
Motor Nerve Hyperexcitability And Muscle Cramps In Machado-joseph Disease - Reply
[No abstract available]661139140Kanai, K., Kuwabara, S., Arai, K., Sung, J.Y., Ogawara, K., Hattori, T., Muscle cramp in Machado-Joseph disease: Altered motor axonal excitability properties and mexiletine treatment (2003) Brain, 126 (PART 4), pp.
D'Abreu A. +3 more
core
Pathophysiological interplay between O-GlcNAc transferase and the Machado-Joseph disease protein ataxin-3. [PDF]
Pereira Sena P +13 more
europepmc +1 more source
PolyQ-expanded ataxin-3 is associated with mitochondrial alterations in Machado-Joseph disease. [PDF]
Simó I +11 more
europepmc +1 more source
Familial spontaneous pneumothorax and Machado-Joseph disease. [PDF]
Pelayo J +3 more
europepmc +1 more source
Short Communication: Restrictions in care following the COVID-19 pandemic severely impacted Machado-Joseph disease patients: a study in the Azores Islands, Portugal. [PDF]
Couto D +4 more
europepmc +1 more source
Circadian rhythms are disrupted in patients and preclinical models of Machado-Joseph disease. [PDF]
Ribeiro RFN +17 more
europepmc +1 more source
Sleep disorders among Aboriginal Australians with Machado-Joseph Disease: Quantitative results from a multiple methods study to assess the experience of people living with the disease and their caregivers. [PDF]
LaGrappe D +10 more
europepmc +1 more source

